| TCMVX | VMVAX | TCMVX / VMVAX | |
| Total Expense Ratio | 0.81 | 0.07 | 1,157% |
| Annual Report Gross Expense Ratio | 0.81 | 0.07 | 1,157% |
| Fund Existence | 23 years | 14 years | - |
| Gain YTD | 7.220 | 8.095 | 89% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.58B | 32.5B | 5% |
| Annual Yield % from dividends | 1.32 | 2.17 | 61% |
| Returns for 1 year | 0.16 | 4.27 | 4% |
| Returns for 3 years | 13.34 | 34.63 | 39% |
| Returns for 5 years | 29.75 | 63.75 | 47% |
| Returns for 10 years | -15.06 | 103.07 | -15% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASGI | 20.80 | 0.11 | +0.53% |
| abrdn Global Infrastructure Income Fund | |||
| PPTY | 30.87 | 0.11 | +0.36% |
| Vident U.S. Diversified Real Estate ETF | |||
| UFEB | 36.07 | 0.12 | +0.33% |
| Innovator US Equity Ultra Bffr ETF™ Feb | |||
| SCHO | 24.45 | 0.02 | +0.08% |
| Schwab Short-Term US Treasury ETF™ | |||
| LFAX | 163.06 | N/A | N/A |
| LifeX 2061 Longevity Income ETF | |||